Inhibition of the angiotensin-converting enzyme N-terminal catalytic domain prevents endogenous opioid degradation in brain tissue
Filip Hanak(University of Minnesota System), Patrick E. Rothwell(University of Minnesota), Kenneth E. Bernstein(Cedars-Sinai Medical Center), Krzysztof Felczak(University of Minnesota), Swati S. More(University of Minnesota)
Cited by 2
Related Papers
DC isoketal-modified proteins activate T cells and promote hypertension
|Journal of Clinical Investigation|2014|533
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488